These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35203467)

  • 1. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia.
    Hromadnikova I; Kotlabova K; Krofta L
    Mol Cell Probes; 2023 Dec; 72():101941. PubMed ID: 37951512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-Trimester Screening for Miscarriage or Stillbirth-Prediction Model Based on MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
    Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Cardiol; 2019 Sep; 291():158-167. PubMed ID: 31151766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L; Sirc J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel First-Trimester Prediction Model for Any Type of Preterm Birth Occurring before 37 Gestational Weeks in the Absence of Other Pregnancy-Related Complications Based on Cardiovascular Disease-Associated MicroRNAs and Basic Maternal Clinical Characteristics.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-Trimester Screening for HELLP Syndrome-Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.
    Hromadnikova I; Kotlabova K; Ivankova K; Vedmetskaya Y; Krofta L
    Int J Cardiol; 2017 Dec; 249():402-409. PubMed ID: 29121743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    Thromb Res; 2016 Jan; 137():126-140. PubMed ID: 26632513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    PLoS One; 2015; 10(9):e0138383. PubMed ID: 26394310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus.
    Hocaoglu M; Demirer S; Senturk H; Turgut A; Komurcu-Bayrak E
    Pregnancy Hypertens; 2019 Jul; 17():5-11. PubMed ID: 31487656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of miR-628-3p and miR-628-5p during the early pregnancy are increased in women who subsequently develop preeclampsia.
    Martinez-Fierro ML; Carrillo-Arriaga JG; Luevano M; Lugo-Trampe A; Delgado-Enciso I; Rodriguez-Sanchez IP; Garza-Veloz I
    Pregnancy Hypertens; 2019 Apr; 16():120-125. PubMed ID: 31056146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.
    Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
    PLoS One; 2017; 12(2):e0171756. PubMed ID: 28182660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.